EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Liposomal formulation of a gold( iii ) metalloantibiotic: a promising strategy against antimicrobial resistance

Alejandro Llamedo, Pablo Rodríguez, Yaiza Gabasa, Raquel G Soengas iD, Humberto Rodríguez-Solla iD, David Elorriaga iD, Francisco J García-Alonso, Sara M Soto

Dalton Transactions · 2024

DOI: 10.1039/d4dt01867b ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2024. Verfasst von Alejandro Llamedo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanovex Biotechnologies S.L., Parque Tecnológico de Asturias Edificio CEEI, 33428 Llanera, Spain. Hauptthemen laut MEDLINE: Liposomes, Anti-Bacterial Agents, Gold, Microbial Sensitivity Tests. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Economía y Competitividad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A novel gold( iii ) metalloantibiotic liposomal formulation was developed. The nanoformulation show high stability and suitable properties for drug delivery, representing a promising strategy to fight against drug-resistant bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesAnti-Bacterial AgentsGoldMicrobial Sensitivity TestsHumansDrug Resistance, BacterialCell SurvivalOrganogold CompoundsCoordination Complexes

Substanzen

LiposomesAnti-Bacterial AgentsGoldOrganogold CompoundsCoordination Complexes

Autor:innen und Institutionen

  • Nanovex Biotechnologies S.L., Parque Tecnológico de Asturias Edificio CEEI, 33428 Llanera, Spain.
  • Departamento de Química Orgánica e Inorgánica, Instituto Universitario de Química Organometálica "Enrique Moles", Universidad de Oviedo, Julián Clavería 8, 33006 Oviedo, Spain. rsoengas@uniovi.es.
  • ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
  • CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Raquel G Soengas, Humberto Rodríguez-Solla, David Elorriaga

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Economía y Competitividad

Zitieren

APA

Llamedo, A., Rodríguez, P., Gabasa, Y., Soengas, R. G., Rodríguez-Solla, H., Elorriaga, D., García-Alonso, F. J., & Soto, S. M. (2024). Liposomal formulation of a gold( iii ) metalloantibiotic: a promising strategy against antimicrobial resistance. Dalton Transactions. https://doi.org/10.1039/d4dt01867b

Vancouver

Llamedo A, Rodríguez P, Gabasa Y, Soengas RG, Rodríguez-Solla H, Elorriaga D, et al. Liposomal formulation of a gold( iii ) metalloantibiotic: a promising strategy against antimicrobial resistance. Dalton Transactions. 2024. doi:10.1039/d4dt01867b

BibTeX
@article{Llamedo2024,
  author = {Llamedo, Alejandro and Rodríguez, Pablo and Gabasa, Yaiza and Soengas, Raquel G and Rodríguez-Solla, Humberto and Elorriaga, David and García-Alonso, Francisco J and Soto, Sara M},
  title = {Liposomal formulation of a gold( iii ) metalloantibiotic: a promising strategy against antimicrobial resistance},
  journal = {Dalton Transactions},
  year = {2024},
  doi = {10.1039/d4dt01867b}
}
Kostenlos starten →